This analysis identified that 122 resulting probe sets of ARSN (VARS, QARS, CARS, NARS, FARS), DTGs (PDE4A, NF1, NBN, CETP, SMAD3, HIST3H2A, TFRC, PTPRC, MTAP, etc), and PPIs (PARD3, RXRB, ATP5C1, HSP90AA1, CD44, THRA, TRAF2, KRT10, MED12, etc) that were correlated with survival in patients with GBM (Table S5). The gene discussed is TFRC; the disease is glioblastoma.